Search Results for keywords:"Personal Privacy"

The National Institute on Aging announced a closed meeting to review and evaluate grant applications related to the Dominantly Inherited Alzheimer Network. This meeting, scheduled for February 10, 2025, from 12:00 p.m. to 5:00 p.m., will be held virtually. The meeting is closed to protect confidential information and personal privacy. Joshua Jin-Hyouk Park, Ph.D., is the contact person for this meeting, and it will adhere to specific sections of the U.S. Code to ensure confidentiality.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting scheduled for May 5, 2021. The meeting concerns the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, specifically focusing on a project titled "Feasibility of a Model Cancer Screening Surveillance Report Using All-Payer Claims Data." It will take place via teleconference from 11:00 a.m. to 6:00 p.m. EDT and is closed to the public to protect confidential information and personal privacy associated with grant applications. For more information, individuals can contact Jaya Raman, Ph.D., the Scientific Review Officer at the CDC.

The National Institutes of Health has announced a closed meeting of the National Institute on Aging's Initial Review Group for the Career Development Facilitating the Transition to Independence Study Section. This meeting, which will be held virtually on February 27-28, 2025, from 10:00 a.m. to 6:00 p.m., will focus on reviewing and evaluating grant applications. The meeting is closed to the public to protect confidential information and personal privacy. For more information, Joshua Park, Ph.D., can be contacted at joshua.park4@nih.gov.

The Centers for Disease Control and Prevention (CDC) will hold a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel on March 4-5, 2025. The meeting aims to review and evaluate grant applications focused on evaluating STEADI-based fall prevention in assisted living facilities. The meeting will be conducted via web conference and is closed to the public to protect confidential information and personal privacy. For further details, contact Aisha L. Wilkes, the Scientific Review Officer at the CDC.

The National Heart, Lung, and Blood Institute announced a closed meeting for the Heart, Lung, and Blood Initial Review Group's NHLBI Single-Site and Pilot Clinical Trials Study Section. This meeting is scheduled for February 26-27, 2025, from 9:00 a.m. to 6:00 p.m. and will be held virtually. It is intended to review and evaluate grant applications but will be closed to the public to protect sensitive information and personal privacy. The contact person for the meeting is Dr. YingYing Li-Smerin, who can be reached via email.

The National Institutes of Health (NIH) announced a closed meeting for the National Institute of Allergy and Infectious Diseases Special Emphasis Panel. This meeting, set for January 7, 2025, will focus on reviewing and evaluating contract proposals related to using artificial intelligence to enhance clinical microscopy for diagnosing infectious diseases. Due to confidential matters concerning trade secrets and personal privacy, the meeting will not be open to the public, and it will take place virtually at the NIH's Rockville, MD location.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP). This meeting is scheduled for February 6, 2025, via teleconference. It will focus on reviewing and evaluating grant applications but will be closed to the public to protect trade secrets and personal privacy. For more information, contact Michael Goldcamp, Ph.D., the Scientific Review Officer.

The National Institute on Drug Abuse (NIDA) will hold a closed meeting on May 6, 2025, of the Board of Scientific Counselors. The meeting will be virtual, running from 10:00 a.m. to 4:45 p.m., and is closed to the public to protect personal privacy, as it involves discussions on the qualifications and performance of individual researchers. The meeting will assess various NIDA programs and projects conducted by its members. For inquiries, Megan E. Bollinger and Deon Harvey are the contacts for more information.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting, which will be held on June 10, 2021, via web conference, is closed to the public due to the possibility of revealing confidential information and personal privacy concerns. The agenda for this meeting includes reviewing and evaluating grant applications related to potential risk factors for Amyotrophic Lateral Sclerosis (ALS). For more information, interested parties can contact Mikel Walters, Ph.D., the Scientific Review Officer.

The National Cancer Institute has announced upcoming meetings focused on reviewing and evaluating grant applications, set to take place virtually on April 10-11, 2025. These meetings will be closed to the public to protect confidential information and personal privacy. They involve the National Cancer Institute Special Emphasis Panel, which aims to explore innovative technologies for cancer research. Interested parties can contact Jeffrey E. DeClue, the Scientific Review Officer, for further information.